FNY Investment Advisers’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
34
-361
| -91% | – | ﹤0.01% | 1029 |
|
|
2025
Q1 | $11K | Sell |
395
-1,854
| -82% | -$51.6K | 0.01% | 473 |
|
|
2024
Q4 | $93K | Buy |
2,249
+2,234
| +14,893% | +$92.4K | 0.05% | 275 |
|
|
2024
Q3 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 585 |
|
|
2024
Q1 | – | Sell |
-15
| Closed | -$1K | – | 746 |
|
|
2023
Q4 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 395 |
|
|
2023
Q3 | – | Sell |
-497
| Closed | -$60K | – | 661 |
|
|
2023
Q2 | $60K | Sell |
497
-11
| -2% | -$1.33K | 0.08% | 149 |
|
|
2023
Q1 | $78K | Buy |
+508
| New | +$78K | 0.09% | 146 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 605 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 727 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 781 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 786 |
|
|
2021
Q4 | – | Sell |
-143
| Closed | -$55K | – | 651 |
|
|
2021
Q3 | $55K | Buy |
143
+31
| +28% | +$11.9K | 0.03% | 322 |
|
|
2021
Q2 | $26K | Sell |
112
-592
| -84% | -$137K | 0.01% | 497 |
|
|
2021
Q1 | $92K | Buy |
704
+223
| +46% | +$29.1K | 0.03% | 324 |
|
|
2020
Q4 | $50K | Buy |
+481
| New | +$50K | 0.01% | 381 |
|
|
2020
Q2 | – | Sell |
-18,675
| Closed | -$559K | – | 487 |
|
|
2020
Q1 | $559K | Buy |
+18,675
| New | +$559K | 0.43% | 52 |
|
|
2019
Q3 | – | Sell |
-21,500
| Closed | -$314K | – | 982 |
|
|
2019
Q2 | $314K | Buy |
+21,500
| New | +$314K | 0.09% | 121 |
|
|
2019
Q1 | – | Sell |
-1,500
| Closed | -$22K | – | 798 |
|
|
2018
Q4 | $22K | Buy |
+1,500
| New | +$22K | 0.01% | 333 |
|